Mor George Adi's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Nov 17, 2022
- Accession no.
- 0001178913-22-004098
- Filed
- Nov 17, 2022
- Trade date
- Oct 28, 2016-Nov 16, 2022
- Filing delay
- 2,211 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.21M. It was filed 2211 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mor George AdiCIK 0001851069 | Director, Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | American Depositary Shares | SSaleDisposed | −324,775 | $2.08 | −$675,532 | 324,775 | Direct | |
| Nov 16, 2022 | American Depositary Shares | SSaleDisposed | −257,248 | $2.08 | −$535,075.84 | 257,247 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2018 | American Depositary Shares | AGrant or awardAcquired | +131,698 | $0.00 | $0 | 131,698 | Direct | |
| Oct 28, 2016 | American Depositary Shares | AGrant or awardAcquired | +33,725 | $0.00 | $0 | 33,725 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.